UCB CELLTECH has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and biotechnology are GRYPHON THERAPEUTICS INC, XENOME LTD and SHIRE ORPHAN THERAPIES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Popplewell Andrew George | 2 |
#2 | Weir Andrew Neil Charles | 1 |
#3 | Spitali Mariangela | 1 |
#4 | Rapecki Stephen Edward | 1 |
#5 | Sehdev Mukesh | 1 |
#6 | King David John | 1 |
#7 | Adams Ralph | 1 |
#8 | Athwal Diljeet Singh | 1 |
#9 | Tickle Simon Peter | 1 |
#10 | Chapman Andrew Paul | 1 |
Publication | Filing date | Title |
---|---|---|
GB0526200D0 | A protein involved in cancer | |
GB0525154D0 | A protein involved in cancer | |
GB0525153D0 | A protein involved in cancer | |
GB0524657D0 | Biological products | |
GB0524656D0 | Biological Products | |
GB0523954D0 | Bioassays | |
GB0523952D0 | Biological products | |
GB0523953D0 | Peptides | |
GB0519659D0 | Therapeutic agents |